Inventor · disambiguated record
David Apelian
Also filed as: APELIAN DAVID
21 granted patents·8 pending applications·164 citations·filing 2006–2020
95Inventor score
Top patents by PatentIndex Score
29 records- 0198US8722054B2Compositions and methods for the treatment or prevention of hepatitis B virus infectionGLOBEIMMUNE INC·Filed 2013·Granted May 13, 2014·85 cites·28 claims
- 0293US9623097B2Yeast-brachyury immunotherapeutic compositionsGLOBEIMMUNE INC·Filed 2015·Granted Apr 18, 2017·12 cites·20 claims
- 0391US10363294B2Yeast-brachyury immunotherapeutic compositionsGLOBEIMMUNE INC·Filed 2017·Granted Jul 30, 2019·7 cites·32 claims
- 0491US9198941B2Yeast-Brachyury immunotherapeutic compositionsGLOBEIMMUNE INC·Filed 2013·Granted Dec 1, 2015·12 cites·22 claims
- 0589US10265393B2Compositions and methods for the treatment or prevention of human immunodeficiency virus infectionGLOBEIMMUNE INC·Filed 2017·Granted Apr 23, 2019·3 cites·19 claims
- 0689US9782473B2Compositions and methods for the treatment or prevention of human immunodeficiency virus infectionGLOBEIMMUNE INC·Filed 2014·Granted Oct 10, 2017·4 cites·18 claims
- 0788US10849971B2Compositions and methods for the treatment or prevention of human immunodeficiency virus infectionGLOBEIMMUNE INC·Filed 2019·Granted Dec 1, 2020·2 cites·18 claims
- 0888US9428556B2Compositions and methods for the treatment or prevention of hepatitis B virus infectionGLOBEIMMUNE INC·Filed 2015·Granted Aug 30, 2016·5 cites·16 claims
- 0985US9943591B2Compositions and methods for the treatment or prevention of hepatitis B virus infectionGLOBEIMMUNE INC·Filed 2016·Granted Apr 17, 2018·3 cites·45 claims
- 1085US8877205B2Yeast-based therapeutic for chronic hepatitis B infectionAPELIAN DAVID·Filed 2012·Granted Nov 4, 2014·6 cites·27 claims
- 1184US9290547B2Yeast-based therapeutic for chronic hepatitis B infectionGLOBEIMMUNE INC·Filed 2014·Granted Mar 22, 2016·4 cites·38 claims
- 1284US8961988B2Compositions and methods for the treatment or prevention of hepatitis B virus infectionGLOBEIMMUNE INC·Filed 2014·Granted Feb 24, 2015·4 cites·94 claims
- 1383US10441650B2Compositions and methods for the treatment or prevention of hepatitis B virus infectionGLOBEIMMUNE INC·Filed 2018·Granted Oct 15, 2019·2 cites·21 claims
- 1483US8501167B2Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancerAPELIAN DAVID·Filed 2008·Granted Aug 6, 2013·7 cites·20 claims
- 1579US9987352B2Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infectionGLOBEIMMUNE INC·Filed 2017·Granted Jun 5, 2018·2 cites·20 claims
- 1676US11944673B2Yeast-brachyury immunotherapeutic compositionsGLOBEIMMUNE INC·Filed 2019·Granted Apr 2, 2024·0 cites·3 claims
- 1776US9579377B2Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infectionKING THOMAS H·Filed 2012·Granted Feb 28, 2017·4 cites·7 claims
- 1875US11938175B2Yeast-brachyury immunotherapeutic compositionsGLOBEIMMUNE INC·Filed 2020·Granted Mar 26, 2024·0 cites·8 claims
- 1975US8728489B2Immunotherapy for chronic hepatitis C virus infectionAPELIAN DAVID·Filed 2009·Granted May 20, 2014·2 cites·19 claims
- 2061US2010034840A1Compositions and methods for eliciting an immune response to escape mutants of targeted therapiesAPELIAN DAVID·Filed 2006·Application pending·0 cites
- 2158US10507235B2Yeast-based immunotherapy for ChordomaGLOBEIMMUNE INC·Filed 2014·Granted Dec 17, 2019·0 cites·34 claims
- 2255US9254320B2Compositions and methods for the treatment or prevention of human adenovirus-36 infectionAPELIAN DAVID·Filed 2011·Granted Feb 9, 2016·0 cites·20 claims
- 2355US2014234375A1Compositions and Methods for Eliciting an Immune Response to Escape Mutants of Targeted TherapiesGLOBELMMUNE INC·Filed 2013·Application pending·0 cites
- 2453US2020046818A1Yeast-based immunotherapy for chordomaGLOBEIMMUNE INC·Filed 2019·Application pending·0 cites
- 2550US2018021360A1Combination Therapy Regimen For Treatment Of Selected HCV GenotypesJANSSEN PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2650US2018021361A1Combination drug treatment for hepatitis c infectionJANSSEN PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2744US2013121964A1Pharmacogenomic and Response-Guided Treatment of Infectious Disease Using Yeast-Based ImmunotherapyAPELIAN DAVID·Filed 2011·Application pending·0 cites
- 2841US2017319572A1Combination drug treatment for hepatitis c infectionJANSSEN PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2939US2017087174A1Combination therapy regimen for treatment of hcvJANSSEN PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →